Commentary

Better support for investigators is essential

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7460.285 (Published 29 July 2004) Cite this as: BMJ 2004;329:285
  1. Sarah Meredith, clinical epidemiologist ([email protected])1
  1. 1 MRC Clinical Trials Unit, London NW1 2DA

    Wald's description of his encounter with the new research ethics committee forms provides a graphic illustration of the frustration and bemusement of most researchers when faced with the hurdles that must now be surmounted to conduct a clinical trial.1 As well as the expansion in the volume of paperwork, the need to understand and comply with the regulatory requirements for good clinical practice, reporting of adverse events, and the supply and labelling of trial drugs make it almost impossible for a clinician to undertake a clinical trial without support. This is not necessarily a bad thing if it leads to better quality studies that are safer for patients, but training and support must be funded and provided if clinical trials in the public interest are to …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe